{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:43:11Z","timestamp":1782250991053,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00428-013-1373-9","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T06:55:41Z","timestamp":1359356141000},"page":"315-321","source":"Crossref","is-referenced-by-count":12,"title":["Is survivin expression prognostic or predictive in malignant pleural mesothelioma?"],"prefix":"10.1007","volume":"462","author":[{"given":"Julija","family":"Hmeljak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Er\u010dulj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u017ee","family":"Pi\u017eem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidor","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viljem","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"\u010cema\u017ear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"C\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"issue":"49","key":"1373_CR1","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/sj.onc.1210515","volume":"26","author":"M Carbone","year":"2007","unstructured":"Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, Jaurand MC, Kjaerheim K, Pass HI, Robinson B, Tsao A (2007) Eighth International Mesothelioma Interest Group. Oncogene 26(49):6959\u20136967","journal-title":"Oncogene"},{"key":"1373_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-3-34","volume":"3","author":"AJ Moore","year":"2008","unstructured":"Moore AJ, Parker RJ, Wiggins J (2008) Malignant mesothelioma. Orphanet J Rare Dis 3:34. doi: 10.1186\/1750-1172-3-34","journal-title":"Orphanet J Rare Dis"},{"issue":"9483","key":"1373_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BWS Robinson","year":"2005","unstructured":"Robinson BWS, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366(9483):397\u2013408","journal-title":"Lancet"},{"issue":"1","key":"1373_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jjco\/hyq159","volume":"41","author":"S Nojiri","year":"2011","unstructured":"Nojiri S, Gemba K, Aoe K, Kato K, Yamaguchi T, Sato T, Kubota K, Kishimoto T (2011) Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan. Jpn J Clin Oncol 41(1):32\u201339. doi: 10.1093\/jjco\/hyq159","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"1373_CR5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi: 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"3","key":"1373_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1843.2004.00602.x","volume":"9","author":"LE Leard","year":"2004","unstructured":"Leard LE, Broaddus VC (2004) Mesothelial cell proliferation and apoptosis. Respirology 9(3):292\u2013299","journal-title":"Respirology"},{"issue":"3","key":"1373_CR7","first-page":"195","volume":"37","author":"J Pizem","year":"2003","unstructured":"Pizem J, Cor A (2003) Survivin\u2014an inhibitor of apoptosis and a new target in cancer. Radiol Oncol 37(3):195\u2013201","journal-title":"Radiol Oncol"},{"issue":"1","key":"1373_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molcel.2007.06.004","volume":"27","author":"T Dohi","year":"2007","unstructured":"Dohi T, Xia F, Altieri DC (2007) Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 27(1):17\u201328. doi: 10.1016\/j.molcel.2007.06.004","journal-title":"Mol Cell"},{"issue":"48","key":"1373_CR9","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/onc.2008.303","volume":"27","author":"DC Altieri","year":"2008","unstructured":"Altieri DC (2008) New wirings in the survivin networks. Oncogene 27(48):6276\u20136284. doi: 10.1038\/onc.2008.303","journal-title":"Oncogene"},{"issue":"4","key":"1373_CR10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbrc.2006.09.143","volume":"350","author":"JY Kim","year":"2006","unstructured":"Kim JY, Chung J-Y, Lee SG, Kim Y-J, Park J-E, Yoo KS, Yoo YH, Park YC, Kim BG, Kim J-M (2006) Nuclear interaction of Smac\/DIABLO with Survivin at G2\/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells. Biochem Biophys Res Commun 350(4):949\u2013954","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1373_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2990.2005.00664.x","volume":"31","author":"J Pizem","year":"2005","unstructured":"Pizem J, Cor A, Zadravec-Zaletel L, Popovic M (2005) Survivin is a negative prognostic marker in medulloblastoma. Neuropathol Appl Neurobiol 31(4):422\u2013428. doi: 10.1111\/j.1365-2990.2005.00664.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"1373_CR12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/path.1388","volume":"200","author":"M Falleni","year":"2003","unstructured":"Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S (2003) Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 200(5):620\u2013626. doi: 10.1002\/Path.1388","journal-title":"J Pathol"},{"key":"1373_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","volume":"430","author":"DC Altieri","year":"2010","unstructured":"Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem J 430:199\u2013205. doi: 10.1042\/Bj20100814","journal-title":"Biochem J"},{"issue":"2","key":"1373_CR14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2559.2004.01925.x","volume":"45","author":"J Pizem","year":"2004","unstructured":"Pizem J, Cor A, Gale N (2004) Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 45(2):180\u2013186. doi: 10.1111\/j.1365-2559.2004.01925.xHIS1925","journal-title":"Histopathology"},{"issue":"2","key":"1373_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2004.10.003","volume":"48","author":"M Falleni","year":"2005","unstructured":"Falleni M, Pellegrini C, Marchetti A, Roncalli M, Nosotti MN, Palleschi A, Santambrogio L, Coggi G, Bosari S (2005) Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. Lung Cancer-J Iaslc 48(2):211\u2013216. doi: 10.1016\/j.lungcan.2004.10.003","journal-title":"Lung Cancer-J Iaslc"},{"issue":"4","key":"1373_CR16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.2121","volume":"211","author":"GJ Gordon","year":"2007","unstructured":"Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Edenfield HR, Glickman JN, Yeap BY, Sugarbaker DJ, Bueno R (2007) Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. J Pathol 211(4):447\u2013454. doi: 10.1002\/path.2121","journal-title":"J Pathol"},{"issue":"2","key":"1373_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15(2):257\u2013260. doi: 10.1093\/annonc\/mdh059","journal-title":"Ann Oncol"},{"key":"1373_CR18","first-page":"128","volume-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart, vol 10. WHO classification of tumours","author":"A Churg","year":"2004","unstructured":"Churg A, Roggli VL, Galateau-Salle F, Cagle PT, Gibbs AR, Hasleton PS, Henderson DW, Vignaud JM, Inai K, Praet M, Ordonez NG, Hammar SP, Testa JR, Gazdar AF, Saracci R, Pugatch R, Samet JM, Weill H, Rusch V, Colby TV, Vogt P, Brambilla E, Travis WD (2004) Mesothelioma. In: Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart, vol 10. WHO classification of tumours. WHO, Geneva, pp 128\u2013136"},{"issue":"11","key":"1373_CR19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00432-011-1030-0","volume":"137","author":"J Hmeljak","year":"2011","unstructured":"Hmeljak J, Erculj N, Dolzan V, Kern I, Cor A (2011) BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients. J Cancer Res Clin Oncol 137(11):1641\u20131651. doi: 10.1007\/s00432-011-1030-0","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"1373_CR20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jjco\/hyp151","volume":"40","author":"CC Lan","year":"2010","unstructured":"Lan CC, Wu YK, Lee CH, Huang YC, Huang CY, Tsai YH, Huang SF, Tsao TCY (2010) Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival. Jpn J Clin Oncol 40(3):234\u2013240. doi: 10.1093\/jjco\/hyp151","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"1373_CR21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humpath.2006.12.013","volume":"38","author":"L Kleinberg","year":"2007","unstructured":"Kleinberg L, Lie AK, Florenes VA, Nesland JM, Davidson B (2007) Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma. Hum Pathol 38(7):986\u2013994. doi: 10.1016\/j.humpath.2007.12.013","journal-title":"Hum Pathol"},{"issue":"2","key":"1373_CR22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2478\/v10019-012-0032-0","volume":"46","author":"V Kovac","year":"2012","unstructured":"Kovac V, Zwitter M, Zagar T (2012) Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: population-based survey of 444 patients. Radiol Oncol 46(2):136\u2013144. doi: 10.2478\/v10019-012-0032-0","journal-title":"Radiol Oncol"},{"issue":"4","key":"1373_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.semcancer.2004.04.002","volume":"14","author":"B Nachmias","year":"2004","unstructured":"Nachmias B, Ashhab Y, Ben-Yehuda D (2004) The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 14(4):231\u2013243. doi: 10.1016\/j.semcancer.2004.04.002","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"1373_CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01243894-200609000-00017","volume":"1","author":"ZB Zhu","year":"2006","unstructured":"Zhu ZB, Makhija SK, Lu BG, Wang MH, Wang SY, Takayama K, Siegal GP, Reynolds PN, Curiel DT (2006) Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses. J Thorac Oncol 1(7):701\u2013711","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1373_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cgt.2009.55","volume":"17","author":"CT Yang","year":"2010","unstructured":"Yang CT, Li JM, Weng HH, Li YC, Chen HC, Chen MF (2010) Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Cancer Gene Ther 17(2):120\u2013130. doi: 10.1038\/cgt.2009.55","journal-title":"Cancer Gene Ther"},{"issue":"Pt 3","key":"1373_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1242\/jcs.115.3.575","volume":"115","author":"P Fortugno","year":"2002","unstructured":"Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC (2002) Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115(Pt 3):575\u2013585","journal-title":"J Cell Sci"},{"issue":"13","key":"1373_CR27","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1158\/0008-5472.CAN-07-0494","volume":"67","author":"RH Stauber","year":"2007","unstructured":"Stauber RH, Mann W, Knauer SK (2007) Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67(13):5999\u20136002. doi: 10.1158\/0008-5472.can-07-0494","journal-title":"Cancer Res"},{"issue":"4","key":"1373_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2559.2006.02514.x","volume":"49","author":"RA Walker","year":"2006","unstructured":"Walker RA (2006) Quantification of immunohistochemistry\u2014issues concerning methods, utility and semiquantitative assessment I. Histopathology 49(4):406\u2013410. doi: 10.1111\/j.1365-2559.2006.02514.x","journal-title":"Histopathology"},{"issue":"5","key":"1373_CR29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ijrobp.2006.12.018","volume":"67","author":"KW Kim","year":"2007","unstructured":"Kim KW, Mutter RW, Willey CD, Subhawong TK, Shinohara ET, Albert JM, Ling G, Cao C, Gi YJ, Lu B (2007) Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests. Int J Radiat Oncol 67(5):1519\u20131525. doi: 10.1016\/j.ijrobp.2006.12.018","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"1373_CR30","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.1016\/j.ijrobp.2006.07.882","volume":"66","author":"K Kim","year":"2006","unstructured":"Kim K (2006) Survivin and Aurora B kinase as therapeutic targets for radiation sensitization in mesothelioma cells. Int J Radiat Oncol 66(3):S471\u2013S472","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"1373_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0215(20001001)88:1<37::AID-IJC6>3.0.CO;2-3","volume":"88","author":"K Kahlos","year":"2000","unstructured":"Kahlos K, Soini Y, Paakko P, Saily M, Linnainmaa K, Kinnula VL (2000) Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma. Int J Cancer 88(1):37\u201343","journal-title":"Int J Cancer"},{"issue":"5","key":"1373_CR32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/1097-0142(20010901)92:5<1245::AID-CNCR1444>3.0.CO;2-G","volume":"92","author":"M Bongiovanni","year":"2001","unstructured":"Bongiovanni M, Cassoni P, De Giuli P, Viberti L, Cappia S, Ivaldi G, Chiusa L, Bussolati G (2001) p27(kip1) immunoreactivity correlates with long-term survival in pleural malignant mesothelioma. Cancer 92(5):1245\u20131250","journal-title":"Cancer"},{"issue":"20","key":"1373_CR33","first-page":"5386","volume":"59","author":"S Donoghue","year":"1999","unstructured":"Donoghue S, Baden HS, Lauder I, Sobolewski S, Pringle JH (1999) Immunohistochemical localization of caspase-3 correlates with clinical outcome in B-cell diffuse large-cell lymphoma. Cancer Res 59(20):5386\u20135391","journal-title":"Cancer Res"},{"issue":"21","key":"1373_CR34","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-06-0231","volume":"12","author":"EC Bruin de","year":"2006","unstructured":"de Bruin EC, van de Velde CJH, van de Pas S, Nagtegaal ID, van Krieken J, Gosens M, Peltenburg LTC, Medema JP, Marijnen CAM (2006) Prognostic value of apoptosis in rectal cancer patients of the Dutch Total Mesorectal Excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res 12(21):6432\u20136436. doi: 10.1158\/1078-0432.ccr-06-0231","journal-title":"Clin Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1373-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1373-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T21:40:30Z","timestamp":1644183630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1373-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1373-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}